HCA
HCA Healthcare, Inc
HCA Healthcare, Inc historical holders
total: 13
Sanders Capital HCA Healthcare, Inc transactions over time
- Total transactions:
- 27
- New positions:
- 2
- Sold out:
- 1
- Added:
- 16
- Reduced:
- 8
- Held since:
- 2020 Q2
- Held for:
- 25 quarters
- Latest activity:
- 2026 Q2
Lewis Sanders has been an institutional investor in HCA Healthcare, Inc (HCA) since 2016 Q1. According to 2026 Q2 report, Lewis Sanders holds 8,828,287 shares with a market value of roughly $3.44B representing 3.45% of their equity portfolio. The fund/company first acquired HCA in 2016 Q1, initially purchasing 109,400 shares. Lewis Sanders later completely sold out the position and reinvested in HCA again in 2020 Q2. Since the initial investment, Sanders Capital has made 26 more transactions in this position.
Does Lewis Sanders still hold HCA?
Yes, Lewis Sanders continues to hold HCA Healthcare, Inc (HCA). According to their 2026 Q2 report, they maintain a position of 8,828,287 shares valued at approximately $3.44B, representing 3.45% of their equity portfolio.
When did Lewis Sanders first invest in HCA?
Lewis Sanders first invested in HCA Healthcare, Inc (HCA) in 2016 Q1 at the reported quarter-end price of $78.05 per share, acquiring 109,400 shares in their initial purchase.
What is Lewis Sanders's average cost basis for HCA?
Based on historical transaction data, Lewis Sanders's estimated cost basis for HCA Healthcare, Inc (HCA) is approximately $151.05 per share. This represents their average reported price* across all buy transactions.
Has Lewis Sanders reinvested in HCA after selling?
Yes, Lewis Sanders has shown renewed interest in HCA Healthcare, Inc (HCA). After completely selling their position, they reinitiated an investment in 2020 Q2, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $151.05
- Weighted AVG sell price:
- $411.58
HCA transactions history by Sanders Capital
27 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
3.45%
|
8,828,287
|
$389.89
|
$3,442,060,818
|
-1.44% (-128,858)
|
-0.06%
|
|
2026 Q1
|
5.05%
|
8,957,145
|
$473.24
|
$4,238,879,300
|
-14.40% (-1,507,023)
|
-0.82%
|
|
2025 Q4
|
5.63%
|
10,464,168
|
$466.86
|
$4,885,301,472
|
-1.98% (-211,495)
|
-0.12%
|
|
2025 Q3
|
5.60%
|
10,675,663
|
$426.20
|
$4,549,967,571
|
-3.85% (-426,920)
|
-0.24%
|
|
2025 Q2
|
5.71%
|
11,102,583
|
$383.10
|
$4,253,399,547
|
-4.00% (-462,564)
|
-0.26%
|
|
2025 Q1
|
5.97%
|
11,565,147
|
$345.55
|
$3,996,336,546
|
-0.78% (-90,416)
|
-0.05%
|
|
2024 Q4
|
5.12%
|
11,655,563
|
$300.15
|
$3,498,417,234
|
+1.01% (+116,826)
|
+0.05%
|
|
2024 Q3
|
6.79%
|
11,538,737
|
$406.43
|
$4,689,688,879
|
+0.16% (+18,175)
|
+0.01%
|
|
2024 Q2
|
5.67%
|
11,520,562
|
$321.28
|
$3,701,326,159
|
+0.73% (+83,557)
|
+0.04%
|
|
2024 Q1
|
6.37%
|
11,437,005
|
$333.53
|
$3,814,584,278
|
+0.29% (+33,002)
|
+0.02%
|
|
2023 Q4
|
5.71%
|
$270.68
|
+4.17% (+456,738)
|
|||
|
2023 Q3
|
5.69%
|
$245.98
|
+0.07% (+7,598)
|
|||
|
2023 Q2
|
6.94%
|
$303.48
|
+3.35% (+354,323)
|
|||
|
2023 Q1
|
6.61%
|
$263.68
|
-1.44% (-154,207)
|
|||
|
2022 Q4
|
6.76%
|
$239.96
|
-3.46% (-385,192)
|
|||
|
2022 Q3
|
5.62%
|
$183.79
|
+0.04% (+4,253)
|
|||
|
2022 Q2
|
4.73%
|
$168.06
|
+14.10% (+1,374,130)
|
|||
|
2022 Q1
|
5.31%
|
$250.62
|
+3.16% (+298,323)
|
|||
|
2021 Q4
|
4.95%
|
$256.92
|
+16.90% (+1,365,582)
|
|||
|
2021 Q3
|
4.45%
|
$242.72
|
+0.25% (+20,334)
|
|||
|
2021 Q2
|
3.78%
|
$206.74
|
+3.42% (+266,566)
|
|||
|
2021 Q1
|
3.54%
|
$188.34
|
+1.59% (+121,700)
|
|||
|
2020 Q4
|
3.33%
|
$164.46
|
+7.57% (+540,322)
|
|||
|
2020 Q3
|
3.05%
|
$124.68
|
+3.78% (+259,582)
|
|||
|
2020 Q2
|
2.49%
|
$97.06
|
new
|
|||
|
2016 Q2
|
0.00%
|
$78.05
|
-100% (-109,400)
|
|||
|
2016 Q1
|
0.07%
|
$78.05
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.